Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Financial Impacts of COVID-19 on Practices: Q&A with Norman Gaylis, MD

Kimberly Retzlaff  |  Issue: September 2020  |  July 17, 2020

As people in the U.S. struggle with increasing cases of COVID-19, the economic toll of the virus is growing, too. Community rheumatology practices are confronting significant financial fallout from stay-at-home orders and fears that keep patients at home, according to Norman Gaylis, MD, a community rheumatologist in Aventura, Fla.

Dr. Norman Gaylis

Dr. Norman Gaylis

Dr. Gaylis started his private practice in 1982. The multi-faceted practice today includes three providers and 32 staff members to whom patients come for rheumatology care, infusion therapy, imaging (X-rays, bone density tests, MRIs), and physical therapy and rehab. Dr. Gaylis spoke with The Rheumatologist about the personal and business decisions he’s had to consider in the months since the novel coronavirus changed the world.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Q: What has been the evolution of COVID-19’s financial impacts on community rheumatology practices?
The actual onset of the COVID-19 epidemic has been like a perfect storm for the fiscal health of most community practices. Initially there was a slow-down effect, and then we started to see a progressive and significant reduction in the number of patients coming into our practice. We ended up being closed for two weeks in April when we just did telemedicine. When we reopened, for the next month we probably saw only 25% of our normal patient population. Not only were we seeing fewer patients, but insurance companies dramatically reduced reimbursements to us for services that we had previously rendered. Effectively, for most practices, this combination created a very tight scenario.

In the return to normal, patients are still apprehensive to come to the office, and they’re even more reluctant given the new surge of COVID-19 cases in Florida and around the country. We’re going backward and noticing that patients are reluctant to visit the office, even though they know it’s relatively safe. Financially, it will be catastrophic if we have to shut the practice down again. We may need more relief down the road if that does happen.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Q: Has there been any relief?
Most of our vendors were understanding and were willing to delay their monthly payments, and our landlord was prepared to give us an abatement. We also had a number of different grants, loans and stimulus monies that, without a doubt, allowed us to keep this practice functioning. These included the Payroll Protection Program, a grant from HHS [the Department of Health and Human Services] and a prospective plan from Medicare.

Page: 1 2 3 | Single Page
Share: 

Filed under:Practice Support Tagged with:community practiceCOVID-19Dr. Norman Gaylisfinancial planningPractice Management

Related Articles

    Dr. Sou-Pan Wu Is the First Recipient of the Norman B. Gaylis Research Award

    May 29, 2019

    The Norman B. Gaylis, MD, Research Award for Rheumatologists in Community Practice is designed to encourage practicing clinicians to conduct their own research for the betterment of patients and rheumatology. The 2019 inaugural honoree is Sou-Pan Wu, MD, who will research gout in the Hmong population in Minnesota…

    Riding Out the Pandemic: A Q&A with Norman Gaylis, MD

    November 30, 2020

    Some aspects of community practice are normalizing amid the ongoing COVID-19 pandemic, but the financial fallout and the need for increased safety precautions remain challenging.

    Dari-designPie / shutterstock.com

    Months After COVID-19 Infection, Rheumatic-Like Symptoms Persist

    April 16, 2021

    As more people get vaccinated for COVID-19, there’s hope that the long days of a pandemic, which has claimed more than 2.5 million lives globally and 500,000 in the U.S., will soon draw to a close and allow daily life to return to normal. However, for some people, this recovery may take longer, because the…

    The Many Facets of COVID-19: Experts Address Basic & Clinical Research Concepts in the COVID-19 Era

    November 23, 2021

    New concepts in autoimmunity & immunology are being discovered daily in research being conducted to understand the SARS-CoV-2 virus and its implications for rheumatology & all fields of medicine. Here are some insights shared by experts during day 1 of the Basic and Clinical Research Conference.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences